Literature DB >> 30528736

CircPUM1 promotes the malignant behavior of lung adenocarcinoma by regulating miR-326.

Jingjing Chen1, Shun Xu2, Shuo Chen3, Zhihong Zong4, Xiaoxu Han1, Yang Zhao3, Hong Shang5.   

Abstract

CircRNAs are reported to be implicated in the development of lung cancer. This study focused on assessing the expression, functions and molecular mechanism of circPUM1 in lung adenocarcinoma. Here, it showed that circPUM1 is significantly upregulated in both lung adenocarcinoma cell lines and tissues. Furthermore, silencing of circPUM1 impaired the proliferation, migration and invasion ability, and increased apoptosis in A549 cells. Nevertheless, overexpression of circPUM1 in SPC-A1 cells has the opposite effect. Silencing of circPUM1 inhibits the tumorigenesis in nude mice. Mechanistically, circPUM1 could sponge miR-326 and promote the expression of its downstream proteins Cyclin D1 and Bcl-2. In summary, this present study revealed that circPUM1 functions as an oncogene to promote the tumorigenesis of lung adenocarcinoma through circPUM1/miR-326/Cyclin D1 and Bcl-2 axis. This indicates that circPUM1 may act as a potential therapeutic target for lung adenocarcinoma.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circular RNA; Lung adenocarcinoma; Proliferation; circPUM1; miR-326

Mesh:

Substances:

Year:  2018        PMID: 30528736     DOI: 10.1016/j.bbrc.2018.11.176

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Effect of circPUM1 on radioresistance of cervical cancer cells through targeting miR-144-3p.

Authors:  Bin Hu; Jinjin Yuan
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2022-04-25

2.  Circular RNA circ_0000043 promotes endometrial carcinoma progression by regulating miR-1271-5p/CTNND1 axis.

Authors:  Dexian Wei; Meirong Tian; Weibo Fan; Xiaojing Zhong; Shuhong Wang; Yahang Chen; Shihong Zhang
Journal:  Arch Gynecol Obstet       Date:  2020-10-31       Impact factor: 2.344

3.  Circular RNA PUM1 performs as a competing endogenous RNA of microRNA-340-5p to mediate DEAD-box helicase 5 to mitigate cerebral ischemia-reperfusion injury.

Authors:  Teng Hu; Di Li; TiePing Fan; XuSheng Zhao; ZhongJun Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Circular RNA circ_0061140 accelerates hypoxia-induced glycolysis, migration, and invasion in lung adenocarcinoma through the microRNA-653/hexokinase 2 (HK2) axis.

Authors:  Shaobin Wang; Hao Zhang; Lixia Xia; Fen Lan
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 5.  The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis.

Authors:  Cornelia Braicu; Alina-Andreea Zimta; Antonia Harangus; Ioana Iurca; Alexandru Irimie; Ovidiu Coza; Ioana Berindan-Neagoe
Journal:  Cancers (Basel)       Date:  2019-04-30       Impact factor: 6.639

6.  Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway.

Authors:  Zhi-Hong Zong; Yao Liu; Shuo Chen; Yang Zhao
Journal:  J Cell Mol Med       Date:  2020-02-19       Impact factor: 5.310

7.  Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1.

Authors:  Qiu Tang; Zhigang Chen; Liangping Zhao; Hai Xu
Journal:  Aging (Albany NY)       Date:  2019-11-26       Impact factor: 5.682

Review 8.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

9.  CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.

Authors:  Mingjun Li; Qianqian Wang; Xiaofei Zhang; Ningning Yan; Xingya Li
Journal:  Cell Cycle       Date:  2021-06-07       Impact factor: 5.173

10.  Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling.

Authors:  Gaofeng Pan; Anwei Mao; Jiazhe Liu; Jingfeng Lu; Junbin Ding; Weiyan Liu
Journal:  Cell Prolif       Date:  2020-01-21       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.